TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Xellia Pharmaceuticals ApS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
266,583
|
301,938
|
241,064 |
| Earnings before taxes |
-285,535
|
-34,238
|
-59,168 |
| Total assets |
282,441
|
465,318
|
502,091 |
| Current assets |
177,471
|
144,009
|
176,139 |
| Current liabilities |
274,157
|
147,308
|
122,177 |
| Equity capital |
-80,207
|
235,423
|
280,077 |
| - share capital |
26,969
|
27,030
|
27,030 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-28.4%
|
50.6%
|
55.8% |
| Turnover per employee |
762
|
863
|
689 |
| Profit as a percentage of turnover |
-107.1%
|
-11.3%
|
-24.5% |
| Return on assets (ROA) | |||
| Current ratio |
64.7%
|
97.8%
|
144.2% |
| Return on equity (ROE) |
356.0%
|
-14.5%
|
-21.1% |
| Change turnover |
-34,683
|
60,874
|
-33,604 |
| Change turnover % |
-12%
|
25%
|
-12% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.